Cargando…
The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice
Persistent inflammation and persistent pain are major medical, social and economic burdens. As such, related pharmacotherapy needs to be continuously improved. The peptide ERα17p, which originates from a part of the hinge region/AF2 domain of the human estrogen receptor α (ERα), exerts anti-prolifer...
Autores principales: | Mallet, Christophe, Boudieu, Ludivine, Lamoine, Sylvain, Coudert, Catherine, Jacquot, Yves, Eschalier, Alain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011567/ https://www.ncbi.nlm.nih.gov/pubmed/33815268 http://dx.doi.org/10.3389/fendo.2021.578250 |
Ejemplares similares
-
The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells
por: Lappano, Rosamaria, et al.
Publicado: (2019) -
Deciphering of a Putative GPER Recognition Domain in ERα and ERα36
por: Acramel, Alexandre, et al.
Publicado: (2022) -
Anti-Hyperalgesic Properties of Menthol and Pulegone
por: Hilfiger, Louis, et al.
Publicado: (2021) -
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer
por: Kampa, Marilena, et al.
Publicado: (2023) -
Interaction of the Anti-Proliferative GPER Inverse Agonist ERα17p with the Breast Cancer Cell Plasma Membrane: From Biophysics to Biology
por: Trichet, Michaël, et al.
Publicado: (2020)